Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

Canada
NITAGs
29 March 2017

NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

  1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
  2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
  3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
  4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.

ca.png
Documents to download

Related News & Events

  • Americas
    NITAGs

    The Caribbean Immunization Technical Advisory Group (CiTAG), the first NITAG of its kind

    27.03.2018

    With 22 small countries/territories, the Caribbean faced a great challenge in stablishing NITAGs. Given the history of Caribbean countries working successfully together in health, the Health Ministers took the wise decision in 2017 to establish a sub-regional NITAG. This is an efficient mechanism to provide independent advice on immunization to the Ministers of Health in keeping with the recommendations of the Global Vaccine Action Plan (GVAP) and PAHO’S Regional Immunization Action Plan (RIAP).

    Read more
  • 24 -25
    May
    Angola
    NITAGs

    first NITAG meeting

    Luanda, Angola
  • 20 -21
    June
    United States of America
    NITAGs

    ACIP meeting

    US-CDC
    1600 Clifton Road, Atlanta